New York to probe Mylan for EpiPen contracts for schools
WASHINGTON, Sept 6 (Reuters) - New York Attorney General Eric Schneiderman has opened a probe into whether Mylan Pharmaceuticals broke antitrust law in writing contracts to sell EpiPens to some schools systems.
A person briefed on the matter said the New York attorney general's office has subpoenaed documents from Mylan over the EpiPen pricing. (Reporting by Diane Bartz and David Shepardson)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.
